Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Am Soc Echocardiogr ; 27(1): 93-100, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24269313

RESUMO

BACKGROUND: In the acute phase of myocardial infarction (MI), infarct size and microvascular obstruction (MVO) are important prognostic factors for cardiovascular outcome. MI size is a major determinant of myocardial function, but the specific effect of MVO is less documented. The aim of this study was to evaluate the impact of MVO on longitudinal myocardial strain assessed by speckle-tracking echocardiography. METHOD: Speckle-tracking echocardiography and contrast-enhanced cardiac magnetic resonance studies were performed in 69 patients 72 hours after first acute MI. Segmental and global longitudinal systolic strain (εL) was measured using speckle-tracking echocardiography. Transmural extent of MI, MI size, and the presence or absence of MVO were assessed using contrast-enhanced cardiac magnetic resonance. Left ventricular (LV) ejection fraction was assessed at 6 months using echocardiography. RESULTS: The mean infarct size was 23 ± 13% of LV mass. MVO was present in 64% of patients. MVO was significantly associated with εL impairment (-7.8 ± 4.9% vs -16.3 ± 6.4%, P < .001), and εL remained significantly worse in MVO-positive segments after adjustment for transmural extent of MI. A εL value > -12.5% predicted the presence of MVO with 83% sensitivity and 75% specificity. On multivariate analysis, global εL and MI size, but not MVO, were identified as independent predictors of LV ejection fraction at follow-up (ß = -0.9, P = .023, and ß = -0.2, P = .034, respectively). CONCLUSION: In the acute phase of MI, segmental and global εL is significantly altered by the presence of MVO, in addition to MI size. However, MI size but not MVO independently predicts LV ejection fraction at follow-up.


Assuntos
Estenose Coronária/diagnóstico por imagem , Estenose Coronária/fisiopatologia , Ecocardiografia/métodos , Microvasos/diagnóstico por imagem , Microvasos/fisiopatologia , Infarto do Miocárdio/diagnóstico por imagem , Infarto do Miocárdio/fisiopatologia , Velocidade do Fluxo Sanguíneo , Circulação Coronária , Estenose Coronária/complicações , Módulo de Elasticidade , Técnicas de Imagem por Elasticidade/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/complicações , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
2.
Europace ; 9(9): 739-43, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17573360

RESUMO

AIMS: To assess whether response to cardiac resynchronization therapy (CRT) is related to myocardial viability in the paced left ventricular (LV) region, evaluated by contractile reserve (CR). Non-response to CRT may partly be due to inefficient pacing by the LV lead located in a fibrotic area. METHODS AND RESULTS: Nineteen patients (64 +/- 13 years, 14 men, 9 ischaemic) with severe heart failure (EF = 27 +/- 8%, QRS = 154 +/- 25 ms) were included in the week after device implantation. Stroke volume (SV) and LV dyssynchrony (by Tissue Doppler Imaging) were successively assessed with CRT on and CRT off. Afterwards, CRT device was maintained off during dobutamine infusion to assess CR in the LV-pacing region. LV end-systolic volume (ESV) was assessed after 6 months to quantify reverse remodelling. CR in the paced LV region (n = 10, 5/9 ischaemic and 5/10 non-ischaemic) was correlated to a reduction in LV dyssynchrony under CRT (120 +/- 76 vs. 78 +/- 64 ms, P = 0.02). Conversely, LV dyssynchrony was unchanged (161 +/- 100 vs. 163 +/- 80 ms) without CR. In desynchronized patients (>65 ms, n = 15), increase in SV under CRT and changes in ESV at 6 months were +22 and -18%, respectively, when CR was present and 0% and +9%, respectively, when absent. CONCLUSION: Acute haemodynamic response and reverse remodelling under CRT require viability in the target region of LV lead.


Assuntos
Estimulação Cardíaca Artificial , Insuficiência Cardíaca/fisiopatologia , Volume Sistólico/efeitos dos fármacos , Idoso , Dobutamina/farmacologia , Ecocardiografia/métodos , Feminino , Insuficiência Cardíaca/terapia , Hemodinâmica , Humanos , Isquemia/patologia , Masculino , Pessoa de Meia-Idade , Contração Miocárdica , Marca-Passo Artificial , Disfunção Ventricular Esquerda , Função Ventricular Esquerda/efeitos dos fármacos , Função Ventricular Esquerda/fisiologia , Remodelação Ventricular
3.
J Am Coll Cardiol ; 46(2): 302-9, 2005 Jul 19.
Artigo em Inglês | MEDLINE | ID: mdl-16022959

RESUMO

OBJECTIVES: We sought to assess the value of transthoracic echocardiography (TTE) using standardized imaging planes for the functional analysis of mitral regurgitation (MR) as well as for postoperative outcome implications. BACKGROUND: The feasibility of mitral valve repair is based on functional assessment of MR, mainly by transesophageal echocardiography (TEE). Considering the recent advances in TTE imaging, the incremental value of TEE in this setting needs to be re-examined. METHODS: Consecutive patients (n = 279; 181 men; median age 68 years [quartiles, 61 to 74]) who underwent surgery for MR were enrolled prospectively in two tertiary care centers. The accuracy of TTE (harmonic imaging) versus TEE for functional assessment of MR was evaluated against surgical findings. RESULTS: Valve repair (n = 237 patients, 85%) or replacement (n = 42) was predicted accurately by TTE in 97% of cases; TEE added significant information for only two patients. In the subgroup of degenerative MR (n = 190), agreement with surgical findings for the localization of prolapsed segments was 91% for TTE (kappa, 0.81) and 93% for TEE (kappa, 0.85) without incremental value of TEE (p = 0.40). Patients with single prolapse of the middle posterior scallop (P2) had a better postoperative outcome as compared with patients who had non-P2 lesions (p = 0.008). Furthermore, mitral replacement predicted by TTE was an independent predictor for postoperative long-term mortality (odds ratio 5.7, 95% confidence interval 1.97 to 16.4, p = 0.001). CONCLUSIONS: In experienced hands, functional assessment of MR by TTE can predict accurately valve repairability and has a strong influence on postoperative outcome. Thus, in most cases preoperative TEE is not mandatory, provided intraoperative TEE is performed.


Assuntos
Ecocardiografia , Insuficiência da Valva Mitral/diagnóstico por imagem , Idoso , Estudos de Casos e Controles , Ecocardiografia/métodos , Ecocardiografia/normas , Ecocardiografia Transesofagiana , Feminino , Implante de Prótese de Valva Cardíaca , Humanos , Cuidados Intraoperatórios , Masculino , Valva Mitral/fisiopatologia , Valva Mitral/cirurgia , Insuficiência da Valva Mitral/mortalidade , Insuficiência da Valva Mitral/fisiopatologia , Insuficiência da Valva Mitral/cirurgia , Cuidados Pré-Operatórios , Estudos Prospectivos , Análise de Sobrevida , Fatores de Tempo
4.
Am J Clin Oncol ; 25(4): 388-90, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12151971

RESUMO

A 60-year-old woman with a history of unresectable colon adenocarcinoma was treated by chemotherapy with a combination of oxaliplatin with leucovorin and fluorouracil. Progressive dyspnea and bilateral pulmonary interstitial infiltrates developed. Bronchoscopy with bronchoalveolar lavage confirmed pulmonary eosinophilia. Clinical and radiologic aspects of eosinophilic lung disease cleared after cessation of this combination of chemotherapy and did not recur after reintroduction of leucovorin/fluorouracil alone, suggesting that oxaliplatin was the causative agent. Care was taken to rule out other possible causes for eosinophilic pneumonia.


Assuntos
Adenocarcinoma/tratamento farmacológico , Antineoplásicos/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Neoplasias Colorretais/tratamento farmacológico , Compostos Organoplatínicos/efeitos adversos , Eosinofilia Pulmonar/induzido quimicamente , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Feminino , Fluoruracila/administração & dosagem , Fluoruracila/efeitos adversos , Humanos , Leucovorina/administração & dosagem , Leucovorina/efeitos adversos , Pessoa de Meia-Idade , Oxaliplatina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA